Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
New York, NY
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Wilmington, NC
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Dublin, OH
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Dublin, OH
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Warwick, RI
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Warwick, RI
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Columbia, SC
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Fort Worth, TX
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Vienna, VA
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated:  9/29/2017
Novo Nordisk Investigational Site
mi
from
Burlington,
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Status: Enrolling
Updated: 9/29/2017
Novo Nordisk Investigational Site
mi
from
Burlington,
Click here to add this to my saved trials
Sleep Health in Preschoolers: a Randomized Controlled Trial
Healthy Sleep Intervention For Preschool Children: A Randomized Controlled Trial of the SHIP Intervention
Status: Enrolling
Updated:  10/4/2017
Seattle Children'S Research Institute
mi
from
Seattle, WA
Sleep Health in Preschoolers: a Randomized Controlled Trial
Healthy Sleep Intervention For Preschool Children: A Randomized Controlled Trial of the SHIP Intervention
Status: Enrolling
Updated: 10/4/2017
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Acupuncture for the Treatment of Insomnia
Acupuncture for the Treatment of Insomnia - A Pilot Study
Status: Enrolling
Updated:  10/5/2017
Center for Integrative Medicine at UPMC Shadyside
mi
from
Pittsburgh, PA
Acupuncture for the Treatment of Insomnia
Acupuncture for the Treatment of Insomnia - A Pilot Study
Status: Enrolling
Updated: 10/5/2017
Center for Integrative Medicine at UPMC Shadyside
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation
Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clarithromycin for the Treatment of Hypersomnia
Clarithromycin for the Treatment of Hypersomnia
Status: Enrolling
Updated:  10/5/2017
Emory Sleep Center
mi
from
Atlanta, GA
Clarithromycin for the Treatment of Hypersomnia
Clarithromycin for the Treatment of Hypersomnia
Status: Enrolling
Updated: 10/5/2017
Emory Sleep Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chamomile for Chronic Primary Insomnia
A Pilot Grant to Examine the Feasibility, Efficacy and Tolerability of a Standardized Chamomile Extract in Treating Chronic Primary Insomnia
Status: Enrolling
Updated:  10/6/2017
University of Michigan Department of Family Medicine
mi
from
Ann Arbor, MI
Chamomile for Chronic Primary Insomnia
A Pilot Grant to Examine the Feasibility, Efficacy and Tolerability of a Standardized Chamomile Extract in Treating Chronic Primary Insomnia
Status: Enrolling
Updated: 10/6/2017
University of Michigan Department of Family Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Melatonin Supplements for Improving Sleep in Individuals With Hypertension
Melatonin Supplementation in Hypertensive Patients
Status: Enrolling
Updated:  10/13/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Melatonin Supplements for Improving Sleep in Individuals With Hypertension
Melatonin Supplementation in Hypertensive Patients
Status: Enrolling
Updated: 10/13/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Obstructive Sleep Apnea in Pregnancy
Obstructive Sleep Apnea in Pregnancy: Development of a Pregnancy-Specific Screening Tool
Status: Enrolling
Updated:  10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Obstructive Sleep Apnea in Pregnancy
Obstructive Sleep Apnea in Pregnancy: Development of a Pregnancy-Specific Screening Tool
Status: Enrolling
Updated: 10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
Sleep, Obesity, and Metabolism in Normal and Overweight Subjects: Effects of CPAP on Glucose Metabolism
Status: Enrolling
Updated:  10/18/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
Sleep, Obesity, and Metabolism in Normal and Overweight Subjects: Effects of CPAP on Glucose Metabolism
Status: Enrolling
Updated: 10/18/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Eating Frequency and Visceral Adipose Tissue, Body Fat, and Obesity Risk in Hispanic College Freshmen
Freshman Health Study
Status: Enrolling
Updated:  10/20/2017
University of Texas at Austin
mi
from
Austin, TX
Eating Frequency and Visceral Adipose Tissue, Body Fat, and Obesity Risk in Hispanic College Freshmen
Freshman Health Study
Status: Enrolling
Updated: 10/20/2017
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Heartland NCORP
mi
from
Decatur, IL
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Heartland NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Wichita NCORP
mi
from
Wichita, KA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Wichita NCORP
mi
from
Wichita, KA
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
University of Rochester
mi
from
Rochester, NY
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Southeast Clinical Oncology Research Program
mi
from
Winston-Salem, NC
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Southeast Clinical Oncology Research Program
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
This is a Study Exploring the Reasons Why People With Alcohol Dependence Have Sleep Disturbances, and Whether or Not a Study Medication, Gabapentin, vs. Placebo, Affects Those Sleep Patterns.
Status: Enrolling
Updated:  10/31/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
This is a Study Exploring the Reasons Why People With Alcohol Dependence Have Sleep Disturbances, and Whether or Not a Study Medication, Gabapentin, vs. Placebo, Affects Those Sleep Patterns.
Status: Enrolling
Updated: 10/31/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Randomized Cross Over Trial of Two Treatments for Sleep Apnea in Veterans With Post-Traumatic Stress Disorder
A Randomized Cross Over Trial of Two Treatments for OSA in Veterans With PTSD
Status: Enrolling
Updated:  11/3/2017
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
A Randomized Cross Over Trial of Two Treatments for Sleep Apnea in Veterans With Post-Traumatic Stress Disorder
A Randomized Cross Over Trial of Two Treatments for OSA in Veterans With PTSD
Status: Enrolling
Updated: 11/3/2017
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Flumazenil for the Treatment of Primary Hypersomnia
A Ten Subject, Double-Blind, Placebo-Controlled Trial of Single Day Dosing of Sublingual Flumazenil in Individuals With Primary Hypersomnia or Excessively Long Total Sleep Time and Excess Endogenous Potentiation of GABA-A Receptors
Status: Enrolling
Updated:  11/6/2017
Emory Sleep Center
mi
from
Atlanta, GA
Flumazenil for the Treatment of Primary Hypersomnia
A Ten Subject, Double-Blind, Placebo-Controlled Trial of Single Day Dosing of Sublingual Flumazenil in Individuals With Primary Hypersomnia or Excessively Long Total Sleep Time and Excess Endogenous Potentiation of GABA-A Receptors
Status: Enrolling
Updated: 11/6/2017
Emory Sleep Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Slow-wave Sleep Deprivation in Depression
Slow-wave Sleep Deprivation as a Possible Treatment for Major Depressive Disorder
Status: Enrolling
Updated:  11/6/2017
Wisconsin Center for Sleep Medicine and Research
mi
from
Madison, WI
Slow-wave Sleep Deprivation in Depression
Slow-wave Sleep Deprivation as a Possible Treatment for Major Depressive Disorder
Status: Enrolling
Updated: 11/6/2017
Wisconsin Center for Sleep Medicine and Research
mi
from
Madison, WI
Click here to add this to my saved trials
Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management
OSA, Sleepiness, and Activity in Diabetes Management
Status: Enrolling
Updated:  11/6/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management
OSA, Sleepiness, and Activity in Diabetes Management
Status: Enrolling
Updated: 11/6/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
Status: Enrolling
Updated:  11/7/2017
University of Michigan
mi
from
Ann Arbor, MI
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
Status: Enrolling
Updated: 11/7/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Home Study of Subjects Who Have Completed a Previous Continuous Negative External Pressure (cNEP) Clinical Trial
Home Study of Subjects With Obstructive Sleep Apnea Who Have Previously Completed an In-Lab Continuous Negative External Pressure (cNEP) Titration and Were Considered to be "Responders"
Status: Enrolling
Updated:  11/15/2017
California Center for Sleep Disorders
mi
from
Alameda, CA
Home Study of Subjects Who Have Completed a Previous Continuous Negative External Pressure (cNEP) Clinical Trial
Home Study of Subjects With Obstructive Sleep Apnea Who Have Previously Completed an In-Lab Continuous Negative External Pressure (cNEP) Titration and Were Considered to be "Responders"
Status: Enrolling
Updated: 11/15/2017
California Center for Sleep Disorders
mi
from
Alameda, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Pulmonary Associates
mi
from
Glendale, AZ
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Pulmonary Associates
mi
from
Glendale, AZ
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
UC San Diego Medical Center
mi
from
La Jolla, CA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
UC San Diego Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
So Cal Institute For Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
So Cal Institute For Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Pacific Sleep Medicine
mi
from
Oceanside, CA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Pacific Sleep Medicine
mi
from
Oceanside, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Stanford University Center for Narcolepsy
mi
from
Redwood City, CA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Stanford University Center for Narcolepsy
mi
from
Redwood City, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Pacific Research Network
mi
from
San Diego, CA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Pacific Research Network
mi
from
San Diego, CA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
PAB Clinical Research
mi
from
Brandon, FL
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Florida Pediatric Research Institute
mi
from
Winter Park, FL
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Florida Pediatric Research Institute
mi
from
Winter Park, FL
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
SleepMed of Central Georgia
mi
from
Macon, GA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
SleepMed of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
University of Illinois Chicago, College of Nursing
mi
from
Chicago, IL
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
University of Illinois Chicago, College of Nursing
mi
from
Chicago, IL
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Kentucky Research Group
mi
from
Louisville, KY
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  11/16/2017
Neurocare, Inc.
mi
from
Newton, MA
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/16/2017
Neurocare, Inc.
mi
from
Newton, MA
Click here to add this to my saved trials